• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2500095 赖脯胰岛素注射液 insulin lispro Injection Biological Products Supplementary Application 2025-05-09 Lilly Suzhou Pharmaceutical Co Ltd view
CYSB2200013 赖脯胰岛素注射液 insulin lispro Injection Biological Products Supplementary Application 2022-01-13 Lilly Suzhou Pharmaceutical Co Ltd view
CYSB2101244 精蛋白人胰岛素混合注射液(30R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2021-10-28 Lilly Suzhou Pharmaceutical Co Ltd view
CXSL2500272 注射用LY4101174 LY4101174 Lyophilized Biological Products(1) New Drug Application 2025-04-08 Lilly Suzhou Pharmaceutical Co Ltd view
CXSL2500049 注射用LY4052031 LY-4052031 Biological Products(1) New Drug Application 2025-01-16 Lilly Suzhou Pharmaceutical Co Ltd view
CXSL2400415 LY3540378注射液 Injection Biological Products(1) New Drug Application 2024-06-27 Lilly Suzhou Pharmaceutical Co Ltd view
CYSB2200275 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2022-12-13 Lilly Suzhou Pharmaceutical Co Ltd view
CYSB2101210 人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2021-10-09 Lilly Suzhou Pharmaceutical Co Ltd view
CXS20020124 头孢克洛缓释片 cefaclor Tablet, extended release Chemical Drugs(4) New Drug Application 2002-02-23 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd Certificate Issued 2002-10-24 view
CXL20023026 LY582563/MCC-478片 alamifovir Tablet Chemical Drugs(1) New Drug Application 2002-11-29 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd Pending Approval 2003-05-09 view
CXL20023025 LY582563/MCC-478片 alamifovir Tablet Chemical Drugs(1) New Drug Application 2002-11-29 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd Certificate Issued 2003-07-07 view
CXL20023024 LY582563/MCC-478 alamifovir Active ingredient Chemical Drugs(1) New Drug Application 2002-11-29 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd Certificate Issued 2003-07-07 view
J0300899 盐酸氟西汀胶囊 fluoxetine hydrochloride Capsule Chemical Drugs Supplementary Application 2003-07-07 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd Certificate Issued 2003-11-27 view
CYHB0500927 头孢克洛胶囊 cefaclor Capsule Chemical Drugs Supplementary Application 2005-08-04 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd Certificate Issued 2005-11-23 view
CYHB1103531 头孢克洛干混悬剂 cefaclor Suspension Chemical Drugs Supplementary Application 2011-05-16 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd Certificate Issued 2016-07-21 view
CYSB2000047 赖脯胰岛素注射液 insulin lispro Injection Biological Products Supplementary Application 2020-03-21 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd In Review 2020-03-20 view
JYHB2000742 盐酸托莫西汀胶囊 atomoxetine hydrochloride Capsule Chemical Drugs Supplementary Application 2020-06-10 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Lilly SA;Lilly Del Caribe Inc Filed 2020-06-16 view
JYHB2000724 奥氮平片 olanzapine Tablet Chemical Drugs Supplementary Application 2020-06-06 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Lilly SA;Eli Lilly Nederland BV Filed 2020-06-16 view
JYHB2000741 盐酸托莫西汀胶囊 atomoxetine hydrochloride Capsule Chemical Drugs Supplementary Application 2020-06-10 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Lilly SA;Lilly Del Caribe Inc Filed 2020-06-16 view
JYHB2000723 奥氮平片 olanzapine Tablet Chemical Drugs Supplementary Application 2020-06-06 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Lilly SA;Eli Lilly Nederland BV Filed 2020-06-16 view